An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia : results of 8722, a randomized phase II study conducted by cancer and leukemia group B

Ej Lee,Stephen L. George,Philip C. Amrein,Paolo Alberto Paciucci,Steven L. Allen,Charles A. Schiffer

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia : results of 8722, a randomized phase II study conducted by cancer and leukemia group B

1998

Ej Lee
Stephen L. George
Philip C. Amrein
Paolo Alberto Paciucci
Steven L. Allen
Charles A. Schiffer

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

Keywords:

Etoposide
Cancer research
Oncology
Cancer
Myeloid leukemia
Phases of clinical research
Leukemia
Mitoxantrone
Pharmacology
Internal medicine
Diaziquone
Medicine
Chemotherapy
Antimetabolite

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations